Agenda


              2010 TRANSLATIONAL MEDICINE ALLIANCE FORUM
MANDARIN ORIENTAL * WASHINGTON, DC * OCTOBER 13–14, 2010

                                            CURRENT AGENDA*
 
WEDNESDAY, OCTOBER 13

6:00–7:00 PM       Reception and Networking
                             Location: Foyer, Grand Ballroom A and B
 
7:00–9:00 PM       Welcome Dinner
                             Location: Grand Ballroom A and B

8:00 PM                Remarks by David Ewing Duncan on The Personalized Health
                             Manifesto: An old-fashioned call to arms and action plan for a
                             new age of healthcare
 
THURSDAY, OCTOBER 14

7:00–7:45 AM        Breakfast
                              Location: Foyer, Grand Ballroom A and B
 
7:45–8:00 AM        Welcome and Opening Address
                              Location: Grand Ballroom A and B
                              Welcome                         Lesa Mitchell (BIO)
                                                                     Ewing Marion Kauffman Foundation
 
                                                                     Margaret A. Anderson (BIO)
                                                                     FasterCures
 
                                                                     Debra R. Lappin (BIO)
                                                                     Council for American Medical Innovation

 
8:00–8:45 AM        Keynote Address           Beat E. Widler, PhD 
                                                                     F. Hoffmann-La Roche Ltd.
  
8:45–9:30 AM        Data Access and Transparency Through Pre-Competitive
                              Platforms

Accelerating the pace of translating scientific discovery into viable medical solutions will rely in large part on accessible and transparent data from quality sources. There is increasing awareness from within the research and advocacy community for the need to develop pre-competitive platforms for these data. This panel will define the barriers to data transparency and access and identify the opportunities to accelerate science. 
 
Moderator                        Debra R. Lappin (BIO)
                                        Council for American Medical Innovation

Panelists                          Aneesh Chopra
                                        Office of Science & Technology Policy
                                        The White House
 
                                                                      Stephen H. Friend, MD, PhD (BIO)
                                                                      Sage Bionetworks
 
                                                                      Heather Joseph
                                                                      SPARC
  
                                                                      John Wilbanks
                                                                      Creative Commons
 
9:30–10:00 AM      Networking Break 
                              Location: Foyer, Grand Ballroom A and B
       
10:00–10:45 AM    Future Role of Academic Research in Translational Medicine
Location: Grand Ballroom A and B
Ongoing scientific and technological advances, greater demand for tangible returns on federal investment in science, and new innovative models in translational medicine are among the forces transforming the medical research enterprise. What role will academic institutions play to truly advance 21st century medicine? What leadership role should the NIH play and which federal programs need to be advanced if we are to truly move translational medicine forward?
 
Moderator                 Sharon Begley
                                 Newsweek
 
Panelists                   Regis B. Kelly, PhD (BIO)
                                 QB3
 
                                 Usama Malik
                                 Pfizer, Inc.
 
                                 George Poste, PhD
                                 Arizona State University
 
                                                           
10:45–11:30 AM    Reverse Engineering: Patient-Driven Translational Science
From advocacy efforts to electronic health records; from biospecimen donation to participation in clinical trials, patients and their data drive medical research. And yet, oftentimes, while research programs acknowledge patients as the ultimate beneficiary, patients are not engaged to drive the process. This panel will explore a medical research system that starts, ends, and is driven by the needs of the patient. What will a patient-driven system look like and how will it be shaped?
 
Moderator                     Margaret A. Anderson (BIO)
                                     FasterCures
 
Panelists                       Frank Douglas, MD, PhD
                                     Austen BioInnovation Institute in Akron
                                    
       Susan Love, MD
       Dr. Susan Love Research Foundation
 
       Franklyn G. Prendergast, MD, PhD
       Mayo Clinic
 

11:30 AM–12:45 PM    Lunch
                                   The Way Forward for Translational Medicine int he US
                                   Moderator                 Lesa Mitchell (BIO)
                                                                    Ewing Marion Kauffman Foundation
 
                                                                    Anna D. Baker, PhD
                                                                    Former Deputy Director,
                                                                                  National Cancer Institute
                                                                    (Current—Private Consultant)
 
                                                                    George Poste, DVM, PhD, RFS
                                                                    Arizona State University
 
 
12:45–1:15 PM      Networking Break 
                              Location: Foyer, Grand Ballroom A and B
 
1:15–2:00 PM        How Rare Disease and Pediatric Medicine Research
                              Are Changing the Landscape 
Location: Grand Ballroom A and B
Medical innovations for pediatric and rare disease patients provide the enterprises’ greatest challenges and opportunities. As we continue to develop more effective and efficient models, medical researchers in rare diseases and pediatrics are paving the way for patient-driven, outcomes-oriented, high-risk with high-reward potential approaches that have and will continue to yield results.  Panelists will focus on how these models are being implemented, key barriers, and what needs to be done to leverage the current outcomes. 
 
Moderator                 Elie Dolgin, PhD
                                 Nature Medicine
  
Panelists                   Christopher P. Austin, MD
                                 National Institutes of Health
 
   Atul Butte, MD, PhD
   Stanford University School of Medicine
      
2:00–2:45 PM        Regulatory Science – What’s at Stake  
This panel will delve deep into what’s prompting the FDA’s resounding call for greater regulatory science. What are the consequences of a regulatory agency that does not have the necessary scientific expertise and inadequate resources? How will regulatory science—or the lack thereof—impact novel therapies in the pipeline? How can advances in this field modernize therapeutic research and development and spur greater investments in translational medicine? 

 Moderator               Timothy R. Franson, MD
                                 B & D Consulting
 
 Panelists                  Vicki L. Seyfert-Margolis, PhD
                                  Science Innovation and Policy, FDA   
 
                                  Ellen V. Sigal, PhD
                                  Friends of Cancer Research
 
                                  Jay J. Schnitzer, MD, PhD (BIO)
                                  Boston Scientific Corporation
 
                                  Scott Weir, PharmD, PhD
                                  Institute for Advancing Medical Innovation
 
2:45–3:30 PM        Rethinking Everything
                              If we were starting over, what would we do differently?
 
 Moderator                Lesa Mitchell (BIO)
                                 Ewing Marion Kauffman Foundation
 
 Panelists                  Jonathan Jacoby
                                 The R.A.R.E. Project
 
   Scott Johnson
   Myelin Repair Foundation
 
   Lt Col Daniel J. Wattendorf, MD
   DARPA
 
3:30-3:45 PM           Closing Remarks
 
* Current agenda as of October 11, 2010. Speaker and timing subject to change.